Dr. Reddy's Laboratories has received complete response letter (CRL) from the US Food and Drug Administration (USFDA) for its versions of NuvaRing and Copaxone. NuvaRing is a birth control device and Copaxone (glatiramer acetate injection) is a multi-billion dollar drug and a prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
